CytomX Therapeutics, Inc. (CTMX)
5.445
-0.02
(-0.46%)
USD |
NASDAQ |
Feb 20, 14:19
CytomX Therapeutics EPS Diluted (TTM) : 0.4182 for Sept. 30, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| REGENXBIO, Inc. | -3.490 |
| ACADIA Pharmaceuticals, Inc. | 1.554 |
| Alnylam Pharmaceuticals, Inc. | 2.257 |
| Savara, Inc. | -0.5351 |
| BioMarin Pharmaceutical, Inc. | 2.669 |